FDMT
Price
$10.81
Change
+$0.72 (+7.14%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
575.92M
100 days until earnings call
Intraday BUY SELL Signals
RCUS
Price
$20.22
Change
+$0.03 (+0.15%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
2.5B
98 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

FDMT vs RCUS

Header iconFDMT vs RCUS Comparison
Open Charts FDMT vs RCUSBanner chart's image
4D Molecular Therapeutics
Price$10.81
Change+$0.72 (+7.14%)
Volume$25.87K
Capitalization575.92M
Arcus Biosciences
Price$20.22
Change+$0.03 (+0.15%)
Volume$14.86K
Capitalization2.5B
FDMT vs RCUS Comparison Chart in %
FDMT
Daily Signal:
Gain/Loss:
RCUS
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
FDMT vs. RCUS commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDMT is a Hold and RCUS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (FDMT: $10.08 vs. RCUS: $20.19)
Brand notoriety: FDMT and RCUS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FDMT: 122% vs. RCUS: 97%
Market capitalization -- FDMT: $617.63M vs. RCUS: $2.5B
FDMT [@Biotechnology] is valued at $617.63M. RCUS’s [@Biotechnology] market capitalization is $2.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FDMT’s FA Score shows that 0 FA rating(s) are green whileRCUS’s FA Score has 0 green FA rating(s).

  • FDMT’s FA Score: 0 green, 5 red.
  • RCUS’s FA Score: 0 green, 5 red.
According to our system of comparison, RCUS is a better buy in the long-term than FDMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FDMT’s TA Score shows that 3 TA indicator(s) are bullish while RCUS’s TA Score has 3 bullish TA indicator(s).

  • FDMT’s TA Score: 3 bullish, 5 bearish.
  • RCUS’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both FDMT and RCUS are a bad buy in the short-term.

Price Growth

FDMT (@Biotechnology) experienced а -6.67% price change this week, while RCUS (@Biotechnology) price change was -0.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

FDMT is expected to report earnings on Feb 27, 2026.

RCUS is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RCUS($2.5B) has a higher market cap than FDMT($576M). FDMT YTD gains are higher at: 80.969 vs. RCUS (35.594). FDMT has higher annual earnings (EBITDA): -213.2M vs. RCUS (-323M). RCUS has more cash in the bank: 831M vs. FDMT (293M). FDMT has less debt than RCUS: FDMT (23.1M) vs RCUS (111M). RCUS has higher revenues than FDMT: RCUS (240M) vs FDMT (33K).
FDMTRCUSFDMT / RCUS
Capitalization576M2.5B23%
EBITDA-213.2M-323M66%
Gain YTD80.96935.594227%
P/E RatioN/AN/A-
Revenue33K240M0%
Total Cash293M831M35%
Total Debt23.1M111M21%
FUNDAMENTALS RATINGS
RCUS: Fundamental Ratings
RCUS
OUTLOOK RATING
1..100
76
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FDMTRCUS
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 9 days ago
81%
Declines
ODDS (%)
Bearish Trend 10 days ago
86%
Bearish Trend 7 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
FDMT
Daily Signal:
Gain/Loss:
RCUS
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FFGTX21.67N/A
N/A
Fidelity Advisor Global Commodity Stk M
RYCKX36.84N/A
N/A
Rydex S&P MidCap 400 Pure Growth C
TINCX2.82N/A
N/A
Templeton Global Dynamic Income A1
CBHMX8.62N/A
N/A
Victory Market Neutral Income Member
SCMIX197.69-3.18
-1.58%
Columbia Seligman Tech & Info Inst2

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with RGNX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
-7.95%
RGNX - FDMT
46%
Loosely correlated
+0.94%
IMTX - FDMT
43%
Loosely correlated
+8.99%
CLDX - FDMT
42%
Loosely correlated
-1.60%
IDYA - FDMT
42%
Loosely correlated
+1.08%
RCUS - FDMT
42%
Loosely correlated
+1.00%
More